9.77
price up icon0.10%   0.010
after-market Handel nachbörslich: 9.96 0.19 +1.94%
loading
Schlusskurs vom Vortag:
$9.76
Offen:
$9.7
24-Stunden-Volumen:
2.60M
Relative Volume:
1.03
Marktkapitalisierung:
$1.15B
Einnahmen:
$2.35B
Nettoeinkommen (Verlust:
$-74.42M
KGV:
-10.39
EPS:
-0.94
Netto-Cashflow:
$150.93M
1W Leistung:
-14.07%
1M Leistung:
+5.62%
6M Leistung:
-2.30%
1J Leistung:
-50.51%
1-Tages-Spanne:
Value
$9.66
$10.03
1-Wochen-Bereich:
Value
$9.2201
$11.81
52-Wochen-Spanne:
Value
$7.06
$33.48

Evolent Health Inc Stock (EVH) Company Profile

Name
Firmenname
Evolent Health Inc
Name
Telefon
571-389-6000
Name
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Name
Mitarbeiter
4,500
Name
Twitter
@EvolentHealth
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
EVH's Discussions on Twitter

Vergleichen Sie EVH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Health Information Services icon
EVH
Evolent Health Inc
9.77 1.33B 2.35B -74.42M 150.93M -0.94
Health Information Services icon
VEEV
Veeva Systems Inc
285.20 45.64B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
61.08 9.68B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
97.41 8.32B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
59.38 11.63B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
36.57 6.57B 906.14M -52.62M 89.62M -0.3621

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-10 Eingeleitet Needham Buy
2024-12-03 Bestätigt BTIG Research Buy
2024-11-08 Herabstufung Stephens Overweight → Equal-Weight
2024-10-11 Eingeleitet KeyBanc Capital Markets Overweight
2024-08-09 Hochstufung Truist Hold → Buy
2024-04-22 Eingeleitet Citigroup Buy
2024-03-01 Eingeleitet Oppenheimer Outperform
2024-01-03 Eingeleitet Barclays Overweight
2023-12-06 Eingeleitet JMP Securities Mkt Outperform
2023-10-16 Eingeleitet UBS Buy
2023-04-12 Eingeleitet Stephens Overweight
2022-11-01 Eingeleitet Truist Hold
2022-07-29 Eingeleitet RBC Capital Mkts Outperform
2022-03-30 Eingeleitet Guggenheim Buy
2021-11-18 Hochstufung JP Morgan Neutral → Overweight
2021-04-29 Fortgesetzt JP Morgan Neutral
2021-01-07 Eingeleitet BTIG Research Buy
2020-07-06 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2020-06-05 Herabstufung Goldman Buy → Neutral
2020-06-02 Herabstufung Cantor Fitzgerald Overweight → Neutral
2018-10-05 Fortgesetzt Leerink Partners Outperform
2018-06-04 Eingeleitet Piper Jaffray Overweight
2018-04-24 Fortgesetzt JP Morgan Neutral
2017-09-20 Eingeleitet KeyBanc Capital Mkts Overweight
2017-06-02 Eingeleitet Robert W. Baird Outperform
2017-03-14 Eingeleitet Oppenheimer Outperform
2017-01-13 Hochstufung Wells Fargo Market Perform → Outperform
2016-10-28 Fortgesetzt JP Morgan Overweight
2016-08-05 Bestätigt FBR Capital Outperform
2016-07-26 Eingeleitet Jefferies Buy
2016-07-13 Bestätigt FBR Capital Outperform
2016-03-29 Eingeleitet FBR Capital Outperform
2016-01-06 Eingeleitet Canaccord Genuity Buy
2015-06-30 Eingeleitet Goldman Buy
2015-06-30 Eingeleitet JP Morgan Overweight
2015-06-30 Eingeleitet Leerink Partners Outperform
2015-06-30 Eingeleitet Sun Trust Rbsn Humphrey Buy
Alle ansehen

Evolent Health Inc Aktie (EVH) Neueste Nachrichten

pulisher
Jul 22, 2025

Is Evolent Health Inc. a good long term investmentExceptional market positioning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Evolent Health Inc. stockSignificant capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Evolent Health Inc. stock priceBreakout stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Evolent Health Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

Truist Securities Raises Price Target for Evolent Health (EVH) | - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

Evolent Health: Truist Securities Maintains Buy, Raises PT to $16 from $14. - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Evolent Health Insiders Added US$1.35m Of Stock To Their Holdings - 富途牛牛

Jul 17, 2025
pulisher
Jul 14, 2025

Evolent Health Announces Q2 Earnings Date and Major Growth Conference Appearance - Stock Titan

Jul 14, 2025
pulisher
Jul 14, 2025

Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry - simplywall.st

Jul 14, 2025
pulisher
Jul 14, 2025

Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - Yahoo Finance

Jul 14, 2025
pulisher
Jul 13, 2025

EVH Press Release: Evolent To Release Second Quarter 2025 Financi... - 富途牛牛

Jul 13, 2025
pulisher
Jul 12, 2025

Evolent Health taps David Lim as chief clinical officer - MSN

Jul 12, 2025
pulisher
Jul 11, 2025

U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView

Jul 11, 2025
pulisher
Jul 11, 2025

BPAS - FinancialContent

Jul 11, 2025
pulisher
Jul 10, 2025

Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Evolent Health Appoints Dr. David Lim as Chief Clinical Officer; John Way as CFO, Performance Suite - citybiz

Jul 09, 2025
pulisher
Jul 09, 2025

Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Former OptumHealth CFO Joins Evolent as Healthcare Giant Expands Specialty Care Leadership - Stock Titan

Jul 09, 2025
pulisher
Jul 07, 2025

Evolent Health stock rating reaffirmed at Buy by Truist on managed care trends - Investing.com Canada

Jul 07, 2025
pulisher
Jul 07, 2025

The Top 5 Analyst Questions From Evolent Health’s Q1 Earnings Call - Yahoo Finance

Jul 07, 2025
pulisher
Jul 03, 2025

SUN extends revolver to 2030, upsizes to $2.46B for Parkland deal | EVH SEC FilingForm 4 - Stock Titan

Jul 03, 2025
pulisher
Jul 03, 2025

JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH) - Insider Monkey

Jul 03, 2025
pulisher
Jun 30, 2025

Evolent Health, Inc.(NYSE: EVH) added to Russell Small Cap Comp Value Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

3 Reasons to Avoid EVH and 1 Stock to Buy Instead - Yahoo Finance

Jun 29, 2025
pulisher
Jun 25, 2025

EVH Stock Up 30% after 5-Day Win Streak - Trefis

Jun 25, 2025
pulisher
Jun 23, 2025

Evolent Health (EVH) Announces Positive Developments Amid Market Concerns | EVH Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Evolent Health stock rating reiterated at Buy by Canaccord on cost trends - Investing.com Canada

Jun 23, 2025
pulisher
Jun 20, 2025

Evolent reiterates Q2 and full year guidance for Adjusted EBITDA - Finansavisen

Jun 20, 2025
pulisher
Jun 19, 2025

Evolent Health Amends Credit Agreement for Flexibility - TipRanks

Jun 19, 2025
pulisher
Jun 10, 2025

EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus - Yahoo Finance

Jun 10, 2025
pulisher
Jun 05, 2025

Evolent Health, Inc. Appoints Shawn Guertin to the Board of Directors and Reconstitutes Compositions of Committees, Effective June 5, 2025 - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

3 Stocks Under $10 in the Doghouse - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolent Health, Inc. To Contact The Firm - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Evolent Health at William Blair Conference: Strategic Growth Amid Challenges - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Evolent Health Reaffirms 2025 Revenue and EBITDA Guidance - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Evolent HealthReaffirms 2025 Revenue Guidance Of $2.06 Bln To $2.11 BlnSEC Filing - marketscreener.com

Jun 03, 2025
pulisher
May 30, 2025

Why Investors Shouldn't Be Surprised By Evolent Health, Inc.'s (NYSE:EVH) 25% Share Price Plunge - simplywall.st

May 30, 2025
pulisher
May 27, 2025

Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance

May 27, 2025
pulisher
May 26, 2025

Evolent Health’s SWOT analysis: value-based care provider faces challenges, opportunities - Investing.com Australia

May 26, 2025

Finanzdaten der Evolent Health Inc-Aktie (EVH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$10.62
price up icon 4.73%
$21.11
price up icon 0.86%
$20.07
price down icon 0.45%
$20.15
price up icon 2.23%
$46.68
price down icon 1.23%
health_information_services WAY
$36.57
price down icon 1.08%
Kapitalisierung:     |  Volumen (24h):